Vitamin D for cancer prevention and survival

Clinical Reviews in Bone and Mineral Metabolism

Volumn 7, Issue 2, 2009, Pages 159-175

  Gorham, Edward D ^a,b   Mohr, Sharif B ^a,b   Garland, Frank C ^a,b   Garland, Cedric F ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

25 Hydroxyvitamin D; Breast neoplasms; Colonic neoplasms; Dose response; Ovarian neoplasms; Pathogenesis; Prevention; Vitamin D

Indexed keywords

EID: 77955898643     PISSN: 15348644     EISSN: 15590119     Source Type: Journal    
DOI: 10.1007/s12018-009-9028-8     Document Type: Article

References (135)

1. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, et al. The role of vitamin D in cancer prevention. Am J Public Health. 2006;96:252-61. (Pubitemid 43167123)
2. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009 (in press).
3. Gorham E, Garland C, Garland F. Acid haze air pollution and breast and colon cancer in 20 Canadian cities. Can J Publ Health. 1989;80:96-100. (Pubitemid 19142164)
4. Garland F, Garland C, Gorham E, Young J Jr. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med. 1990;19:614-22.
5. Gorham ED, Garland FC, Garland CF. Sunlight and breast cancer incidence in the USSR. Int J Epidemiol. 1990;19:820-4.
6. Grant WB. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer. 2002;94:1867-75. (Pubitemid 34241126)
7. Grant WB. An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer. 2002;94:272-81. (Pubitemid 34049069)
8. Freedman D, Dosemeci M, McGlynn K. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med. 2002;59:257-62. (Pubitemid 34309914)
9. Boscoe FP, Schymura MJ. Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002. BMC Cancer. 2006;6:264.
10. Lowe LC, Guy M, Mansi JL, Peckitt C, Bliss J, Wilson RG, et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer. 2005;41:1164-9. (Pubitemid 40725575)
11. Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1991-7. (Pubitemid 41161213)
12. Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, et al. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer - results of a large case-control study. Carcinogenesis. 2008;29:93-9. (Pubitemid 351201746)
13. Garland C, Garland F. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 1980;9:227-31. (Pubitemid 11238851)
14. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet. 1985;1:307-9. (Pubitemid 15157126)
15. Garland C, Comstock G, Garland F, Helsing K, Shaw E, Gorham E. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet. 1989;2:1176-8. (Pubitemid 19275448)
16. Mizoue T. Ecological studies of solar radiation and cancer mortality in Japan. Health Phys. 2004;87:532-8. (Pubitemid 40340625)
17. Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2004;13:1502-8. (Pubitemid 39202318)
18. Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, Virtamo J, et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control. 1997;8:615-25. (Pubitemid 27330494)
19. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354:684-96. (Pubitemid 43247139)
20. Lefkowitz ES, Garland CF. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol. 1994;23:1133-6.
21. Mohr SB, Garland CF, Gorham ED, Grant WB, Garland FC. Relationship between low ultraviolet B irradiance and higher breast cancer risk in 107 countries. Breast J. 2008;14:255-60. (Pubitemid 351678057)
22. Tworoger SS, Lee IM, Buring JE, Rosner B, Hollis BW, Hankinson SE. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:783-8. (Pubitemid 46650582)
23. Grant W, Garland C. The association of solar ultraviolet B with reducing risk of cancer: multifactorial ecological analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res. 2006;26:2687-99. (Pubitemid 44155550)
24. Grant WB. Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res. 2003;164:371-7.
25. Martinez ME, Giovannucci EL, Colditz GA, Stampfer MJ, Hunter DJ, Speizer FE, et al. Calcium, vitamin D, and the occurrence of colorectal cancer among women. J Natl Cancer Inst. 1996;88:1375-82. (Pubitemid 26329755)
26. Kearney J, Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, et al. Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men. Am J Epidemiol. 1996;143:907-17. (Pubitemid 26131098)
27. Pritchard RS, Baron JA, Gerhardsson de Verdier M. Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden. Cancer Epidemiol Biomarkers Prev. 1996;5:897-900. (Pubitemid 26382983)
28. LaVecchia C, Braga C, Negri E, Francesci S, Russo A, et al. Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer. 1997;73:525-30. (Pubitemid 28005316)
29. Salazar-Martinez E, Lazcano-Ponce EC, Gonzalez Lira-Lira G, Escudero-De los Rios P, Hernandez-Avila M. Nutritional determinants of epithelial ovarian cancer risk: a case-control study in Mexico. Oncology. 2002;63:151-7.
30. Salazar-Martinez E, Lazcano-Ponce E, Sanchez-Zamorano LM, Gonzalez-Lira G, Escudero DELRP, Hernandez-Avila M. Dietary factors and endometrial cancer risk. Results of a case-control study in Mexico. Int J Gynecol Cancer. 2005;15:938-45. (Pubitemid 41783106)
31. Lin J, Manson JE, Lee IM, Cook NR, Buring JE, Zhang SM. Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med. 2007;167:1050-9. (Pubitemid 46835793)
32. John E, Schwartz G, Dreon D, Koo J. Vitamin D and breast cancer risk: The NHANES I epidemiologic follow-up study, 1971-1975 to 1992. Cancer Epidemiol Biomarkers Prev. 1999;8:399-406. (Pubitemid 29230543)
33. John EM, Dreon DM, Koo J, Schwartz GG. Residential sunlight exposure is associated with a decreased risk of prostate cancer. J Steroid Biochem Mol Biol. 2004;89-90:549-52. (Pubitemid 38844346)
34. John EM, Koo J, Schwartz GG. Sun exposure and prostate cancer risk: evidence for a protective effect of early-life exposure. Cancer Epidemiol Biomarkers Prev. 2007;16:1283-6. (Pubitemid 46984972)
35. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85:1586-91. (Pubitemid 46890428)
36. Garland C, Grant W, Mohr S, Gorham E, Garland F. What is the dose-response relationship between vitamin D and cancer risk? Nutr Rev. 2007;65:S91-5.
37. Abbas S, Chang-Claude J, Linseisen J. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Int J Cancer. 2009;124:250-5.
38. Garland CF, Gorham ED, Mohr SB, Grant WB, Giovannucci EL, Lipkin M, et al. Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol. 2007;103:708-11. (Pubitemid 46420519)
39. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295-300.
40. Lipkin M, Newmark HL. Vitamin D, calcium and prevention of breast cancer: a review. J Am Coll Nutr. 1999;18:392S-7S. (Pubitemid 29455710)
41. Brenner B, Russell N, Albrecht S, Davies R. The effect of dietary vitamin D3 on the intracellular calcium gradient in mammalian colonic crypts. Cancer Lett. 1998;12:43-53. (Pubitemid 28230784)
42. Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR, et al. 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet. 2001;357:1673-4. (Pubitemid 32568244)
43. Cross HS, Lipkin M, Kallay E. Nutrients regulate the colonic vitamin D system in mice: relevance for human colon malignancy. J Nutr. 2006;136:561-4. (Pubitemid 43363735)
44. Freedman DM, Looker AC, Chang SC, Graubard BI. Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst. 2007;99:1594-602.
45. Chlebowski R, Johnson K, Kooperberg C, et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2008;100:1581-91.
46. Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcif Tissue Int. 1988;43:199-201.
47. Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM, et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab. 2005;90:4119-23. (Pubitemid 41058184)
48. Scragg R, Camargo CA Jr. Frequency of leisure-time physical activity and serum 25-hydroxyvitamin D levels in the US population: results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2008;168:577-86.
49. Hiatt R, Krieger N, Lobaugh B, Drezner M, Vogelman J, Orentreich N. Prediagnostic serum vitamin D and breast cancer. J Natl Cancer Inst. 1998;90:461-3. (Pubitemid 28160638)
50. Janowsky EC, Lester GE, Weinberg CR, Millikan RC, Schildkraut JM, Garrett PA, et al. Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk. Public Health Nutr. 1999;2:283-91. (Pubitemid 29446591)
51. Freedman DM, Chang SC, Falk RT, Purdue MP, Huang WY, McCarty CA, et al. Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2008;17:889-94. (Pubitemid 351536420)
52. Garland CF, Gorham ED, Baggerly CA, Garland FC. Re: Prospective study of vitamin D and cancer mortality in the United States. J Natl Cancer Inst. 2008;100:826-7. (Pubitemid 351809664)
53. Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW. Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis. Am J Epidemiol. 1995;142:608-11.
54. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med. 2007;32:210-6. (Pubitemid 46223622)
55. Garland CF, Mohr SB, Gorham ED, Grant WB, Garland FC. Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer. Am J Prev Med. 2006;31:512-4. (Pubitemid 44880583)
56. Mohr SB, Garland CF, Gorham ED, Grant WB, Garland FC. Is ultraviolet B irradiance inversely associated with incidence rates of endometrial cancer?: an ecological study of 107 countries. Prev Med. 2007;45:327-31. (Pubitemid 350047481)
57. Mohr SB, Gorham ED, Garland CF, Grant WB, Garland FC. Are low ultraviolet B and high animal protein intake associated with risk of renal cancer? Int J Cancer. 2006;119:2705-9. (Pubitemid 44691329)
58. Mohr S, Gorham E, Garland C, Grant W, Garland F. Are low UVB and high animal energy intake associated UVB and vitamin D higher incidence rates of renal cancer? Int J Cancer. 2006;120.
59. Stolzenberg-Solomon RZ, Vieth R, Azad A, Pietinen P, Taylor PR, Virtamo J, et al. A prospective nested case-control study of vitamin d status and pancreatic cancer risk in male smokers. Cancer Res. 2006;66:10213-9. (Pubitemid 44672077)
60. Abnet CC, Chen W, Dawsey SM, Wei WQ, Roth MJ, Liu B, et al. Serum 25(OH)-vitamin D concentration and risk of esophageal squamous dysplasia. Cancer Epidemiol Biomarkers Prev. 2007;16:1889-93. (Pubitemid 47450522)
61. Knekt P, Jarvinen R, Dich J, Hakulinen T. Risk of colorectal and other gastro-intestinal cancers after exposure to nitrate, nitrite and N-nitroso compounds: a follow-up study. Int J Cancer. 1999;80:852-6. (Pubitemid 29108859)
62. Zou XN, Lu SH, Liu B. Volatile N-nitrosamines and their precursors in Chinese salted fish - a possible etological factor for NPC in china. Int J Cancer. 1994;59:155-8. (Pubitemid 24343354)
63. Dallorso ME, Gil S, Pawlak E, Lema F, Marquez A. 1,25(OH)2 vitamin D concentration in the plasma of Solanum glaucophyllum intoxicated rabbits. Aust Vet J. 2001;79:419-23. (Pubitemid 33639581)
64. Ding EL, Mehta S, Fawzi WW, Giovannucci EL. Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: reanalysis of Women's Health Initiative randomized trial. Int J Cancer. 2008;122:1690-4. (Pubitemid 351413414)
65. Pratt W, Taylor P, Goldstein A. Principles of drug action: the basis of pharmacology. New York: Churchill Livingstone; 1990.
66. Mohr S, Garland C, Gorham E, Grant W, Highfill R, Garland F. Mapping vitamin D deficiency, breast cancer and colorectal cancer. Proceedings of the ESRI international user conference, San Diego, CA; 2005. p. 1778.
67. Goodwin P, Ennis M, Pritchard K, Koo J, Hood N, Lunenfeld S, et al. Vitamin D deficiency is common at breast cancer diagnosis and is associated with a significantly higher risk of distant recurrence and death in a prospective cohort study of T1-3, N0-1, M0 BC (abstract). American Society for Clinical Oncology Annual Meeting, Chicago, IL, May 17, 2008.
68. Ng K, Meyerhardt JA, Wu K, Feskanich D, Hollis BW, Giovannucci EL, et al. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol. 2008;26:2984-91.
69. Porojnicu AC, Dahlback A, Moan J. Sun exposure and cancer survival in Norway: changes in the risk of death with season of diagnosis and latitude. Adv Exp Med Biol. 2008;624:43-54.
70. Robsahm TE, Tretli S, Dahlback A, Moan J. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control. 2004;15:149-58.
71. Stryd RP, Gilbertson TJ, Brunden MN. A seasonal variation study of 25-hydroxyvitamin D3 serum levels in normal humans. J Clin Endocrinol Metab. 1979;48:771-5. (Pubitemid 9172111)
72. Garland C, Gorham, Mohr S, Grant W, Garland F. Pooled analysis of vitamin D and breast cancer. American Association for Cancer Research Annual Meeting, San Diego, CA; 2008.
73. Ferlay J, Bray F, Pisani P, Parkin D. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC Cancer-Base No. 5. version 2.0. http://www-dep.iarc.fr/ (2008). Accessed 10 July 2008.
74. Columbia University: Center for International Earth Science Information Network. http://sedac.ciesin.columbia.edu/ozone/rtm/mval.html (2008). Accessed 10 July 2008.
75. National Aeronautics and Space Administration. International Satellite Cloud Climatology Project database. http://isccp.giss.nasa.gov/products/ isccpDsets.html. Accessed 31 December 2008.
76. National Academy of Sciences - Institute of Medicine, Food, Nutrition Board. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academy Press; 1997.
77. Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9:730-56.
78. Vilenchik MM, Knudson AG. Radiation dose-rate effects, endogenous DNA damage, and signaling resonance. Proc Natl Acad Sci U S A. 2006;103:17874-9. (Pubitemid 44852253)
79. Cairns J. Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc Natl Acad Sci U S A. 2002;99:10567-70.
80. Jones S, Chen WD, Parmigiani G, Diehl F, Beerenwinkel N, Antal T, et al. Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci USA. 2008;105:4283-8. (Pubitemid 351754372)
81. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell. 1996;84:345-57. (Pubitemid 26058560)
82. Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat. 1995;154:8-20. (Pubitemid 26101385)
83. Pearson GW, Hunter T. Real-time imaging reveals that noninvasive mammary epithelial acini can contain motile cells. J Cell Biol. 2007;179:1555-67.
84. Gradstein F, Ogg J, Smith A. A geologic time scale. Cambridge: Cambridge University Press; 2004.
85. Wicha MS. Identification of murine mammary stem cells: implications for studies of mammary development and carcinogenesis. Breast Cancer Res. 2006;8:109.
86. Shimkin M. Contrary to nature. Bethesda, MD: U.S. Department of Health, Education and Welfare; 1979.
87. Liu S, Dontu G, Wicha MS. Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res. 2005;7:86-95. (Pubitemid 40704127)
88. Dawkins R. The selfish gene. New York: Oxford University Press; 2006.
89. Zheng B, Mills AA, Bradley A. Introducing defined chromosomal rearrangements into the mouse genome. Methods. 2001;24:81-94. (Pubitemid 32846446)
90. Okamura M, Yasuno N, Ohtsuka M, Tanaka A, Shikazono N, Hase Y. Wide variety of color- and shape mutants regenerated from leaf cultures irradiated with ion beams. Nuclear Instruments and Methods in Physics Research B. 2003;206:574-8.
91. Eigeliene N, Harkonen P, Erkkola R. Effects of estradiol and medroxyprogesterone acetate on morphology, proliferation and apoptosis of human breast tissue in organ cultures. BMC Cancer. 2006;6:246.
92. Ruotsalainen H, Sipila L, Vapola M, Sormunen R, Salo AM, Uitto L, et al. Glycosylation catalyzed by lysyl hydroxylase 3 is essential for basement membranes. J Cell Sci. 2006;119:625-35.
93. Pitelka DR, Taggart BN, Hamamoto ST. Effects of extracellular calcium depletion on membrane topography and occluding junctions of mammary epithelial cells in culture. J Cell Biol. 1983;96:613-24. (Pubitemid 13131321)
94. Contreras RG, Miller JH, Zamora M, Gonzalez-Mariscal L, Cereijido M. Interaction of calcium with plasma membrane of epithelial (MDCK) cells during junction formation. Am J Physiol. 1992;263:C313-8.
95. Whelan J, McEntee MF. Dietary (n-6) PUFA and intestinal tumorigenesis. J Nutr. 2004;134:3421S-6S. (Pubitemid 39587584)
96. Raimondi F, Santoro P, Barone MV, Pappacoda S, Barretta ML, Nanayakkara M, et al. Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation. Am J Physiol Gastrointest Liver Physiol. 2008;294:G906-13. (Pubitemid 351520062)
97. Debruyne PR, Bruyneel EA, Li X, Zimber A, Gespach C, Mareel MM. The role of bile acids in carcinogenesis. Mutat Res. 2001;480-481:359-69. (Pubitemid 32744842)
98. Newmark H, Wargovich M, Bruce W. Colon cancer, and dietary fat, phosphate, and calcium: a hypothesis. JNCI. 1984;72:1321-5.
99. Pettifor JM. Vitamin D and/or calcium deficiency rickets in infants and children: a global perspective. Indian J Med Res. 2008;127:245-9. (Pubitemid 351936151)
100. Kutluk G, Cetinkaya F, Basak M. Comparisons of oral calcium, high dose vitamin D and a combination of these in the treatment of nutritional rickets in children. J Trop Pediatr. 2002;48:351-3. (Pubitemid 36024535)
101. Garland C, Garland F, Gorham E. Colon cancer parallels rickets. In: Lipkin M, Newmark H, Kelloff G, editors. Calcium, vitamin D, and prevention of colon cancer. Bethesda, MD/Boca Raton, FL: National Cancer Institute/CRC Press; 1991. p. 81-109.
102. Murillo G, Matusiak D, Benya RV, Mehta RG. Chemopreventive efficacy of 25-hydroxyvitamin D3 in colon cancer. J Steroid Biochem Mol Biol. 2007;103:763-7. (Pubitemid 46401332)
103. Vantieghem K, Overbergh L, Carmeliet G, De Haes P, Bouillon R, Segaert S. UVB-induced 1, 25(OH)2D3 production and vitamin D activity in intestinal CaCo-2 cells and in THP-1 macrophages pretreated with a sterol Delta7-reductase inhibitor. J Cell Biochem. 2006;99:229-40. (Pubitemid 44297967)
104. Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick MF, Kiel DP. A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc. 2007;55:234-9. (Pubitemid 46184399)
105. Talwar SA, Aloia JF, Pollack S, Yeh JK. Dose response to vitamin D supplementation among postmenopausal African American women. Am J Clin Nutr. 2007;86:1657-62. (Pubitemid 350232180)
106. Aloia JF, Talwar SA, Pollack S, Yeh J. A randomized controlled trial of vitamin D3 supplementation in African American women. Arch Intern Med. 2005;165:1618-23. (Pubitemid 41124156)
107. Wicklow BA, Taback SP. Feasibility of a type 1 diabetes primary prevention trial using 2000 IU vitamin D3 in infants from the general population with increased HLA-associated risk. Ann N Y Acad Sci. 2006;1079:310-2. (Pubitemid 44968739)
108. Saadi HF, Dawodu A, Afandi BO, Zayed R, Benedict S, Nagelkerke N. Efficacy of daily and monthly high-dose calciferol in vitamin D-deficient nulliparous and lactating women. Am J Clin Nutr. 2007;85:1565-71. (Pubitemid 46890425)
109. Basile LA, Taylor SN, Wagner CL, Horst RL, Hollis BW. The effect of high-dose vitamin D supplementation on serum vitamin D levels and milk calcium concentration in lactating women and their infants. Breastfeed Med. 2006;1:27-35.
110. Kislal FM, Dilmen U. Effect of different doses of vitamin D on osteocalcin and deoxypyridinoline in preterm infants. Pediatr Int. 2008;50:204-7. (Pubitemid 351414779)
111. Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am J Clin Nutr. 2007;85:6-18. (Pubitemid 46067609)
112. Vieth R. The risk of additional vitamin D. Ann Epidemiol. 2008 (in press).
113. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77:204-10. (Pubitemid 36015393)
114. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69:842-56. (Pubitemid 29205056)
115. 3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001;73:288-94.
116. Vieth R. Critique of the consideration for establishing the for vitamin D tolerable intake: critical need for revision. J Nutr. 2006;136:1117-22.
117. 2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004;89:5387-91.
118. 3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 2008;93:677-81.
119. Hall PM. Preventing kidney stones: calcium restriction not warranted. Cleve Clin J Med. 2002;69:885-8. (Pubitemid 35363561)
120. Meschi T, Schianchi T, Ridolo E, Adorni G, Allegri F, Guerra A, et al. Body weight, diet and water intake in preventing stone disease. Urol Int. 2004;72(1):29-33. (Pubitemid 38608359)
121. Pak CY. Medical stone management: 35 years of advances. J Urol. 2008;180:813-9.
122. Spivacow FR, Negri AL, del Valle EE, Calvino I, Fradinger E, Zanchetta JR. Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol. 2008;23:1129-33.
123. Massey LK. Dietary influences on urinary oxalate and risk of kidney stones. Front Biosci. 2003;8:s584-94. (Pubitemid 39140184)
124. Kramer HJ, Choi HK, Atkinson K, Stampfer M, Curhan GC. The association between gout and nephrolithiasis in men: the health professionals' follow-up study. Kidney Int. 2003;64:1022-6. (Pubitemid 37013838)
125. Cramer JS, Forrest K. Renal lithiasis: addressing the risks of austere desert deployments. Aviat Space Environ Med. 2006;77:649-53.
126. Curhan GC. Dietary calcium, dietary protein, and kidney stone formation. Miner Electrolyte Metab. 1997;23:261-4. (Pubitemid 27475357)
127. Scragg R, Jackson R, Holdaway I, Lim T, Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol. 1990;19:559-63. (Pubitemid 20331800)
128. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168:1174-80. (Pubitemid 351831400)
129. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001;358:1500-3. (Pubitemid 33055701)
130. Mohr SB, Garland CF, Gorham ED, Garland FC. The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia. 2008;51:1391-8.
131. Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses. 1986;21:193-200. (Pubitemid 17201931)
132. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296:2832-8. (Pubitemid 44969183)
133. 3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988;67:373-8.
134. Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland CF, Heaney RP, et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr. 2007;85:649-50. (Pubitemid 46393494)
135. Kakarala RR, Chandana SR, Harris SS, Kocharla LP, Dvorin E. Prevalence of vitamin D deficiency in uninsured women. J Gen Intern Med. 2007;22:1180-3. (Pubitemid 47038057)